ASSESSMENT OF SYSTEMIC INFLAMMATORY INDICATORS AND THEIR CORRELATION IN ALZHEIMER'S DISEASE PATIENTS

Abstract

Background: The identification of Alzheimer's disease biomarkers can aid in tracking the disease's progression. Serum IL-6
levels are higher in people with Alzheimer's disease than in healthy individuals, according to a number of earlier research.
Serum CRP levels in Alzheimer's disease patients have been found to rise in a small number of investigations. There are
few research on albumin evaluation.
Aim: The purpose of this study was to determine whether systemic inflammatory indicators, such as albumin levels, C-
reactive protein (CRP), and interleukin-6 (IL-6), may play a part in the onset of Alzheimer's disease (AD) and whether they
are related to the severity of the disease